15862-36-9

Basic information

• Product Name: 2,3-DIBROMO-5-NITRO PYRIDINE
• Synonyms: 2,3-DIBROMO-5-NITRO PYRIDINE
• CAS NO: 15862-36-9
• Molecular Formula: C₅H₂Br₂N₂O₂
• Molecular Weight: 281.89
• EINECS: 125-856-9
• Product Categories: Pyridine;Boronic Acid;Pyridines;pyridine series;Heterocycle-Pyridine series
• Mol File: 15862-36-9.mol
• Article Data: 4

Chemical Properties

• Melting Point: 78℃
• Boiling Point: 311℃
• Flash Point: 142℃
• Appearance: /
• Density: 2.221
• Vapor Pressure: 0.00104mmHg at 25°C
• Refractive Index: 1.649
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -5.60±0.20(Predicted)
• CAS DataBase Reference: 2,3-DIBROMO-5-NITRO PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-DIBROMO-5-NITRO PYRIDINE(15862-36-9)
• EPA Substance Registry System: 2,3-DIBROMO-5-NITRO PYRIDINE(15862-36-9)

Safety Data

• Hazard Codes: Xn
• Statements: 20/21/22-36/37/38
• Safety Statements: 26-36
• Hazardous Substances Data: 15862-36-9(Hazardous Substances Data)

Usage

Uses

2,3-Dibromo-5-nitropyridine

InChI:InChI=1/C5H2Br2N2O2/c6-4-1-3(9(10)11)2-8-5(4)7/h1-2H

Upstream product

• 5418-51-9 5-nitro-2-hydroxypyridine 
• 15862-33-6 3-bromo-2-hydroxy-5-nitropyridine 

Downstream Products

• 1119088-68-4 3-bromo-2-(3-methoxyphenyl)-5-nitropyridine 
• 186593-42-0 3-bromo-2-methyl-5-nitropyridine 
• 186593-43-1 5-amino-3-bromo-2-methylpyridine 
• 74919-31-6 3-bromo-2-ethoxy-5-nitropyridine 
• 1119090-69-5 ethyl 2-(6-(3-methoxyphenyl)-5-phenylpyridin-3-ylamino)-5-methylbenzoate 
• 1119085-69-6 2-(6-(3-methoxyphenyl)-5-phenylpyridin-3-ylamino)-5-methylbenzoic acid 
• 1119088-65-1 6-(3-methoxyphenyl)-5-phenylpyridin-3-amine 
• 1119088-71-9 2-(3-methoxyphenyl)-5-nitro-3-phenylpyridine 

Relevant articles and documents

Compounds for inflammation and immune-related uses

The invention relates to certain compounds or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

AZABIPHENYLAMINOBENZOIC ACID DERIVATIVES AS DHODH INHIBITORS

New azabiphenylaminobenzoic acid derivatives having the chemcial structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of the dehydroorotate dihydrogenase (DHODH)